Added to YB: 2025-03-20
Pitch date: 2025-01-22
TEM [neutral]
Tempus AI, Inc.
+42.02%
current return
Author Info
Golden Bear Capital is where swing trading meets deep research. Sign up for the newsletter.
Company Info
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties.
Market Cap
$12.5B
Pitch Price
$49.72
Price Target
N/A
Dividend
N/A
EV/EBITDA
-82.74
P/E
-59.11
EV/Sales
11.84
Sector
Life Sciences Tools and Services
Category
growth
Scouting the Titans of Tomorrow 🌐
TEM (overview): AI-driven precision medicine platform with 200+ petabytes of data, 50% US oncologist penetration. $693M 2024 revenue (+30% YoY), expanding beyond oncology. Strong pharma partnerships, $900M+ contract value. Ambry acquisition to accelerate growth, profitability by 2025. Risks: pre-profit, competition, regulatory challenges.
Read full article (11 min)